Hubungan Kadar Procalcitonin Saat Awal Masuk Pada Pasien Pneumonia Komunitas Terhadap Kematian 30 Hari

  LAMPIRAN 1 LEMBAR PENJELASAN KEPADA SUBJEK PENELITIAN Selamat pagi/siang Bapak/Ibu, pada hari ini , saya, dr. Junita, M. Kes akan

melakukan penelitian yang berjudul ”Hubungan Kadar Procalcitonin Saat Awal

  

Masuk Pada Pasien dengan Pneumonia Komunitas Terhadap Kematian 30 Hari”.

Penelitian ini bertujuan melihat apakah ada hubungan semakin tinggi kadar

procalcitonin pada saat awal pasien pneumonia komunitas masuk ke rumah sakit

semakin tinggi pula angka kematian 30 hari. Sebagai informasi, procalcitonin

merupakan suatu prohormon calcitonin yang dikenal sebagai petanda inflamasi

(peradangan) yang konsentrasinya hanya meningkat pada infeksi bakteri dan tetap

rendah pada infeksi virus, banyak digunakan untuk mendeteksi penyakit infeksi

dan salah satunya adalah pneumonia, sehingga dapat memudahkan untuk

mengidentifikasi derajat keparahan dan pemberian antibiotik sejak awal pada

pasien dengan pneumonia komunitas.

  Kepada Bapak/Ibu yang bersedia mengikuti penelitian ini nantinya akan

diminta mengisi surat persetujuan ikut dalam penelitian, mengikuti wawancara

untuk mencari adanya hal-hal yang dapat mengganggu penelitian, dilakukan

pengukuran tekanan darah (TD), rontgen dada, pemeriksaan laboratorium awal

berupa pemeriksaan darah sebanyak 10 cc oleh ahlinya untuk menilai parameter

darah rutin, fungsi hati, fungsi ginjal, kadar procalcitonin, kultur darah serta kultur

dahak. Kemudian peserta penelitian akan di follow up selama 30 hari dengan

sebagian Bapak/Ibu akan mendapat terapi/obat sesuai dengan standar pengobatan

pneumonia komunitas.

  Setelah hasil akhir diperoleh, nantinya akan terlihat apakah terdapat

hubungan kadar procalcitonin saat awal pasien masuk ke rumah sakit dengan

jumlah kematian 30 hari. Segala biaya pemeriksaan laboratorium dan penyediaan

obat menjadi tanggung jawab peneliti. Bila masih terdapat pertanyaan, maka

Bapak/Ibu dapat menghubungi saya pada: Nama : dr. Junita, M. Kes Alamat : Jl. Lizardi Putra Kompleks Setiabudi Vista Blok H No. 7 Medan Telepon : (061)- 76658246 dan 081397342684 Peneliti, (dr. Junita, M.Kes)

  LAMPIRAN 2 LEMBAR PERSETUJUAN SETELAH PENJELASAN (INFORMED CONSENT ) -------------------------------------------------------------------------------------------- Saya yang bertanda tangan dibawah ini : Nama :........................................................................................... Alamat :........................................................................................... Umur :........................ Tahun Jenis Kelamin : Laki-laki/ Perempuan. No Telp/HP : Setelah mendapat penjelasan dari peneliti tentang kebaikan dan keburukan prosedur penelitian ini , menyatakan bersedia ikut serta dalam penelitian tentang ” Hubungan Kadar Procalcitonin Saat Awal Masuk Pada Pasien dengan Pneumonia Komunitas Terhadap Kematian 30 Hari ”. Apabila sewaktu-waktu saya mengundurkan diri dari penelitian ini, kepada saya tidak dituntut apapun. Demikianlah surat persetujuan bersedia ikut dalam penelitian ini saya buat, untuk dapat digunakan seperlunya.

  Medan, ...........................2011 Saksi Yang Memberi Pernyataan

(.............................................) (.............................................)

  LAMPIRAN 3 LEMBAR KERJA PROFIL PESERTA PENELITIAN : : Tanggal MR No.Peserta :

Data Peserta

I.

  IDENTITAS PRIBADI.

  Nama : Kode : X / Y Tempat/Tanggal Lahir :

Jenis Kelamin : Laki-laki/Perempuan.

Pendidikan Terakhir : Pekerjaan :

Status : Kawin/Belum Kawin.

No Telp/Hp :................................

  II. PEMERIKSAAN FISIK x

  Sensorium: Pernafasan : .......... /menit o

  

Tekanan Darah : ............. mmHg Temperatur :........... C

x

  Nadi : ............. /menit

  III. PEMERIKSAAN LABORATORIUM

Parameter Nilai

  Hb (gr/dl)

  3 Leukosit (mm ) Ureum (mg/dl) Creatinin (mg/dl) Procalcitonin (ng/ml) Kultur Darah Kultur Dahak

  IV. PEMERIKSAAN RADIOLOGI Foto Thorax PA :

  LAMPIRAN 4 LEMBAR PERSETUJUAN KOMITE ETIK PENELITIAN “ Hubungan Kadar Procalcitonin Saat Awal Masuk Pada Pasien

   Dengan Pneumonia Komunitas Terhadap Kematian 30 Hari ” dr. Junita, M. Kes

  1 Juli 2011

  LAMPIRAN 5 UJI STATISTIK NPar Tests Frequency Table

One-Sample Kolmogorov-Smirnov Test

  Jenis kelamin

  Valid Frequency Percent Valid Percent

  56.1 56.1 100.0 57 100.0 100.0 Laki-laki Perem puan Total

  32

  43.9

  43.9

  43.9

  25

  b.

  57 52.39 14.092 .079 .075 -.079 .595 .871 57 110.88 18.056 .235 .235 -.133 1.777 .004 57 70.53 11.087 .250 .250 -.171 1.886 .002

  Calculated from data.

  a.

  Test distribution is Normal.

  N Mean Std. Deviation Normal Parameters ^a,b Absolute Positive Negative Most Extreme Differences Kolmogorov-Smirnov Z As ymp. Sig. (2-tailed)

  57 1.95 1.540 .240 .240 -.139 1.808 .003 Umur TDS TDD Nadi Laju pernpasan Suhu Hb Leukos it Ureum D-DIMER PCT Skor Curb 65

  57 28.02 3.975 .165 .123 -.165 1.243 .091 57 37.260 .8202 .168 .168 -.062 1.269 .080 57 9.995 2.6320 .069 .069 -.069 .524 .946 57 14387.06 5081.705 .116 .070 -.116 .873 .432 57 47.879 54.1849 .277 .277 -.241 2.092 .000 57 1897.14 1476.110 .202 .202 -.112 1.524 .019 57 8.7825 17.87021 .312 .296 -.312 2.355 .000

  57 95.04 10.316 .151 .122 -.151 1.142 .147

  Cumulative Percent

  Crosstab

  Skor Curb 65 0-2 3-5 Total

  PCT < 0,1 Count

  12

  12 % within PCT

  100.0% .0% 100.0% % within Skor Curb 65 34.3% .0% 21.1% % of Total

  21.1% .0% 21.1% 0,1-0,24 Count

  4

  4 % within PCT 100.0% .0% 100.0% % within Skor Curb 65

  11.4% .0% 7.0% % of Total

  7.0% .0% 7.0% 0,25-0,49 Count

  1

  1 % within PCT

  100.0% .0% 100.0% % within Skor Curb 65

  2.9% .0% 1.8% % of Total

  1.8% .0% 1.8% >= 0,5 Count

  18

  22

  40 % within PCT

  45.0% 55.0% 100.0% % within Skor Curb 65

  51.4% 100.0% 70.2% % of Total

  31.6% 38.6% 70.2% Total Count

  35

  22

  57 % within PCT

  61.4% 38.6% 100.0% % within Skor Curb 65

  100.0% 100.0% 100.0% % of Total 61.4% 38.6% 100.0%

  Chi-Square Te sts As ymp. Sig.

  Value df (2-sided)

  a

  Pearson Chi-S quare 15.227 3 .002

  Lik elihood Ratio 20.977 3 .000

  Linear-by-Linear 13.976 1 .000

  As soc iation N of V alid Cases

  57 a. 5 c ells (62.5%) have ex pec ted c ount les s than 5. The minimum expected count is .39.

  PCT * Skor Curb 65 Crosstab Skor Curb 65 3-5 0-2 Total

  PCT >= 0,25 Count

  

22

  19

  41 % within PCT 53.7% 46.3% 100.0% % within Skor Curb 65

  100.0% 54.3% 71.9% % of Total 38.6% 33.3% 71.9% < 0,25 Count

  16

  16 % within PCT .0% 100.0% 100.0% % within Skor Curb 65 .0% 45.7% 28.1% % of Total .0% 28.1% 28.1% Total Count

  

22

  35

  57 % within PCT 38.6% 61.4% 100.0% % within Skor Curb 65

  100.0% 100.0% 100.0% % of Total 38.6% 61.4% 100.0%

  Chi-Square Tests As ymp. Sig. Exact Sig. Exact Sig.

  Value df (2-sided) (2-sided) (1-sided)

  b

  Pearson Chi-Square 13.982 1 .000

  a

  Continuity Correction 11.809 1 .001

  Likelihood Ratio 19.409 1 .000

  Fis her's Exact Test .000 .000

  Linear-by-Linear 13.737 1 .000

  As sociation N of Valid Cases

  57 a. Computed only for a 2x2 table b. 0 cells (.0%) have expected count less than 5. The minimum expected count is 6.

  18.

  Death day 30 * Skor Curb 65 * PCT Crosstab

  Skor Curb 65 PCT

  0-2 3-5 Total >= 0,25 Death day Hidup Count

  17

  5

  22

  30 % within Death day 30 77.3% 22.7% 100.0% % within Skor Curb 65

  89.5% 22.7% 53.7% % of Total

  41.5% 12.2% 53.7% Mati Count

  2

  17

  19 % within Death day 30

  10.5% 89.5% 100.0% % within Skor Curb 65

  10.5% 77.3% 46.3% % of Total 4.9% 41.5% 46.3%

  Total Count

  19

  22

  41 % within Death day 30

  46.3% 53.7% 100.0% % within Skor Curb 65 100.0% 100.0% 100.0% % of Total

  46.3% 53.7% 100.0% < 0,25 Death day Hidup Count

  15

  15

  30 % within Death day 30 100.0% 100.0% % within Skor Curb 65

  93.8% 93.8% % of Total

  93.8% 93.8% Mati Count

  1

  1 % within Death day 30

  100.0% 100.0% % within Skor Curb 65

  6.3% 6.3% % of Total

  6.3% 6.3% Total Count

  16

  16 % within Death day 30

  100.0% 100.0% % within Skor Curb 65

  100.0% 100.0% % of Total

  100.0% 100.0%

  

Chi-Square Tests

As ymp. Sig. Exact Sig. Exact Sig.

  PCT Value df (2-sided) (2-sided) (1-sided)

  b

  >= 0,25 Pearson Chi-Square 18.266 1 .000

  a

  Continuity Correction 15.680 1 .000 Likelihood Ratio

  20.249 1 .000 Fis her's Exact Test

  .000 .000 Linear-by-Linear

  17.820 1 .000 As sociation N of Valid Cases

  41

  c

  < 0,25 Pearson Chi-Square .

  N of Valid Cases

  16 a. Computed only for a 2x2 table b. 0 cells (.0%) have expected count les s than 5. The minimum expected count is 8.80.

  c. No statistics are computed because Skor Curb 65 is a cons tant.

  Death day 30 * Skor Curb 65 * PCT

Crosstab

  Hidup Mati

  19 10.5% 89.5% 100.0% 11.1% 77.3% 47.5%

  5.0% 42.5% 47.5%

  18

  22

  40 45.0% 55.0% 100.0%

  100.0% 100.0% 100.0% 45.0% 55.0% 100.0%

  Count % within Death day 30 % within Skor Curb 65 % of Total Count % within Death day 30 % within Skor Curb 65 % of Total Count % within Death day 30 % within Skor Curb 65 % of Total Count % within Death day 30 % within Skor Curb 65 % of Total Count % within Death day 30 % within Skor Curb 65 % of Total Count % within Death day 30 % within Skor Curb 65 % of Total Count % within Death day 30 % within Skor Curb 65 % of Total Count % within Death day 30 % within Skor Curb 65 % of Total Count % within Death day 30 % within Skor Curb 65 % of Total Count % within Skor Curb 65 % of Total

  Death day

  2

  30 Total Hidup Death day

  30 Total Hidup Death day

  30 Total Hidup Mati

  Death day

  30 Total PCT < 0,1 0,1-0,24 0,25-0,49 >= 0,5

  0-2 3-5 Skor Curb 65

  Total

  17

  21 76.2% 23.8% 100.0% 88.9% 22.7% 52.5% 40.0% 12.5% 52.5%

  11

  4

  11 100.0% 100.0%

  91.7% 91.7% 91.7% 91.7%

  1

  1 100.0% 100.0%

  8.3% 8.3% 8.3% 8.3%

  12

  12 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%

  4 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%

  5

  4

  4 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%

  1

  1 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%

  1

  1 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%

  16

  r =0,947

  Chi-Square Tests As ymp. Sig. Exact Sig. Exact Sig.

  PCT Value df (2-sided) (2-sided) (1-sided)

  b < 0,1 Pearson Chi-Square .

  N of Valid Cases

  12

  c

  0,1-0,24 Pearson Chi-Square .

  N of Valid Cases

  4

  c

  0,25-0,49 Pearson Chi-Square .

  N of Valid Cases

  1

  d

  >= 0,5 Pearson Chi-Square 17.378 1 .000

  a

  Continuity Correction 14.826 1 .000

  Likelihood Ratio 19.212 1 .000

  Fis her's Exact Test .000 .000

  Linear-by-Linear 16.943 1 .000

  As sociation N of Valid Cases

  40

  a. Computed only for a 2x2 table b.

  No statistics are computed because Skor Curb 65 is a constant.

  c.

  No statistics are computed because Death day 30 and Skor Curb 65 are cons tants .

  d.

  0 cells (.0%) have expected count less than 5. The minimum expected count is 8.55.

  T-Test Group Sta tisti cs

  St d. E rror Death day 30 N Mean St d. Deviat ion Mean

  D-DIME R Hidup 37 1156.32 936.074 153.890 Mati 20 3267.65 1309.924 292.908

  PCT Hidup 37 3.1184 7.85272 1.29098 Mati 20 19.2610 25.42306 5.68477

  

Independent Samples Test

Levene's Test for

Equality of Variances t-test for Equality of Means

  95% Confidence Interval of the Difference Mean Std. Error

  F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper D-DIMER Equal variances 3.059 .086 -7.044 55 .000 -2111.326 299.728 -2711.994 -1510.658 as sumed

  Equal variances

• 6.381 29.741 .000 -2111.326 330.873 -2787.306 -1435.345 not ass umed PCT Equal variances 23.406 .000 -3.582

  55 .001 -16.14262 4.50638 -25.17361 -7.11163 as sumed Equal variances not ass umed

  Correlations Laju Nadi pernpasan Leukosit Ureum D-DIMER PCT Skor Curb 65

  Nadi Pearson Correlation 1 .480** .126 .104 .444** .247 .464** Sig. (2-tailed) .000 .352 .442 .001 .064 .000 N

  57

  57

  57

  57

  57

  57

  57 Laju pernpasan Pearson Correlation .480** 1 .355** .281* .736** .482** .767** Sig. (2-tailed)

  .000 .007 .035 .000 .000 .000 N

  57

  57

  57

  57

  57

  57

  57 Leukosit Pearson Correlation .126 .355** 1 .446** .288* .033 .322* Sig. (2-tailed) .352 .007 .001 .030 .805 .015 N

  57

  57

  57

  57

  57

  57

  57 Ureum Pearson Correlation .104 .281* .446** 1 .345** .346** .401** Sig. (2-tailed) .442 .035 .001 .009 .008 .002 N

  57

  57

  57

  57

  57

  57

  57 D-DIMER Pearson Correlation

.444** .736** .288* .345**

1 .667** .947** Sig. (2-tailed)

  .001 .000 .030 .009 .000 .000 N

  57

  57

  57

  57

  57

  57

  57 PCT Pearson Correlation .247 .482** .033 .346** .667** 1 .622** Sig. (2-tailed)

  .064 .000 .805 .008 .000 .000 N

  57

  57

  57

  57

  57

  57

  57 Skor Curb 65 Pearson Correlation .464** .767** .322* .401** .947** .622**

  1 Sig. (2-tailed) .000 .000 .015 .002 .000 .000 N

  57

  57

  57

  57

  57

  57

  57 **. Correlation is significant at the 0.01 level (2-tailed).

• . Correlation is significant at the 0.05 level (2-tailed).

  LAMPIRAN 6 DAFTAR RIWAYAT HIDUP I.

IDENTITAS PRIBADI

  Nama : dr. Junita, M.Kes Tempat/Tgl Lahir : Meureudu / 01 Juni 1974 Suku/Bangsa : Aceh / Indonesia Agama : Islam Alamat : Jl. Lizardi Putra, Komplek Setiabudi Vista Blok H No. 7 Medan

II. KELUARGA

  Suami : dr. Togu Siburian Anak : 1. Nada Shafiya Siburian

  2. Raihan Salsabila Siburian

  3. M. Hafiz Furqani Siburian

III. PENDIDIKAN

  1. SDN 27 Kodya Banda Aceh, NAD Tamat Tahun 1986

  2. SLTPN 4 Kodya Banda Aceh, NAD Tamat Tahun 1989

  3. SMAN 2 Kodya Banda Aceh, NAD Tamat Tahun 1992

  4. FK Universitas Islam Sumatera Utara Tamat Tahun 2001

  5. Pasca Sarjana Universitas Sumatera Utara Tamat Tahun 2006

IV. RIWAYAT PEKERJAAN

  1. Dokter RSU Pematang Siantar, Medan ( 2001 – 2003) 2. Dokter Puskesmas Cot Bau dan Puskesmas Paya Seunara, Kodya.

  Sabang ( 2006-2007)

  3. Dokter RSUD Sabang, Kodya Sabang (2007-sekarang)

  

4. Staf Pengajar Fakultas Kedokteran Abulyatama Banda Aceh

( 2006-2009)

  5. Dokter Konsultan Daerah di RSUD Aceh Singkil, Kab.

  Aceh Singkil, Mei - November 2012

V. KEANGGOTAAN PROFESI

  1. Ikatan Dokter Indonesia (IDI) Medan

  2. Persatuan Ahli Penyakit Dalam Indonesia (PAPDI) Sumatera Utara

VI. Kursus Penataran

   USG PUSKI Tahap I 1.

VII. KARYA ILMIAH DI DEPARTEMEN PENYAKIT DALAM

  

1. Junita, E.N.Keliat, Alwinsyah Abidin. In Oral Presentation. Hubungan Kadar

Procalcitonin Saat Awal Masuk Pada Pasien Pneumonia Komunitas Terhadap Skor CURB-65. National Congresss-XII of Indonesian Respirology Society in conjunction with Makassar Respiratory Scientific Meeting-III, Grand Clarion Hotel Makassar, 25 -27 Mei 2012. Pemenang kedua presentasi oral.

  2. Junita, Elias Tarigan, Leonardo B Dairi, Lukman Hakim Zain. Melanosis

Colli. Laporan Kasus. Kongres Nasional XV Perhimpunan Dokter

Spesialis Penyakit Dalam Indonesia (KOPAPDI XV) Medan 2012, Hotel Grand Aston, 12 - 15 Desember 2012.

PARTISIPASI DALAM KEGIATAN ILMIAH VIII.

  1. Peserta Simposium “Achieving Ambitious Glycaemic Target in Diabetes : Stepwise Intensification of Insulin Treatment from Basal to Basal Plus/ Bolus). Medan, 12 Juli 2009.

  2. Peserta Simposium “Early Insulin inisiation, how, when and what insulin according to daily practice need . Medan, 21 November 2009.

  3. Peserta Simposium “Update On Wound Management”, Hotel JW Mariott, Medan, 16 Oktober 2010.

  4. Peserta Simposium “Update on Diabetes Management and Medical Nutrition Therapy” , Hotel Grand Aston, 17 April 2010.

  5. Peserta Workshop Hepatitis Kronik, Gastroentero-Hepatologi Update VIII 2010, Convention Hall Hotel Danau Toba Medan, 21 Oktober 2010

  6. Peserta Workshop Perdarahan Saluran Cerna, Gastroentero-Hepatologi Update VIII 2010, Convention Hall Hotel Danau Toba Medan, 21 Oktober 2010.

  7. Peserta Workshop Ascites, Gastroentero-Hepatologi Update VIII 2010, Convention Hall Hotel Danau Toba Medan, 21 Oktober 2010.

  8. Peserta Seminar “Current Management in Internal Medicine” dan

Workshop Ultrasonography. Pertemuan Ilmiah Tahunan (PIT) XI 2010.

  Departemen Ilmu Penyakit Dalam. Medan, 01 – 03 April 2010.

  

9. Peserta Simposium “ New Advance in Treatment of Type 2 Diabetes”.

  Medan, 18 Juli 2010.

  10. Panitia Simposium “Clinical Rheumatology in Daily Practice”, Rheumatology Update 2010. Medan, 31 Juli - 01Agustus 2010.

  11. Peserta Simposium “Clinical Rheumatology in Daily Practice”, Rheumatology Update 2010. Medan, 31 Juli - 01Agustus 2010.

  

12. Peserta Simposium “Hiperglicemia of patients with diabetes mellitus in

clinical practice” . Medan, 28 November 2010.

  

13. Peserta Pelatihan Program Pengembangan Pendidikan Keprofesian

Berkelanjutan FK USU Seminar “New Trends in Vaccination And Infection Control” . Ruang Seminar FK USU, 15 Januari 2011

  

14. Peserta Pelatihan Program Pengembangan Pendidikan Keprofesian

Berkelanjutan FK USU Workshop Tatalaksana Demam Berdarah Dengue.

  Ruang Seminar FK USU, 15 Januari 2011.

  

15. Peserta Seminar Hepatitis Update. Ruang Seminar FK USU, 23 Februari

2011.

  

16. Peserta Pelatihan Program Pengembangan Pendidikan Keprofesian

Berkelanjutan Ultrasonografi Tahap Pertama bagi Spesialis dan PPDS Penyakit Dalam. Departemen Penyakit Dalam FK USU dan PUSKI. Medan, 21-24 Maret 2011.

  

17. Panitia Simposium dan Workshop PIT XII 2011 Penyakit Dalam,

Pertemuan Ilmiah Nasional PERPARI. Medan 28-30 April 2011.

  

18. Peserta Simposium PIT XII 2011 Penyakit Dalam, Pertemuan Ilmiah

Nasional PERPARI. Medan 28-30 April 2011.

  

19. Peserta Workshop “Nutritional Problems in Critical Ill Patients”. PIT XII

2011 Penyakit Dalam, Pertemuan Ilmiah Nasional PERPARI. Medan 28-

  30 April 2011.

  

20. Peserta Workshop “Insulin In Daily Practice”. PIT XII 2011 Penyakit

Dalam, Pertemuan Ilmiah Nasional PERPARI. Medan 28-30 April 2011.

  

21. Peserta Simposium “ The Future Management Cardiovascular Management”. The 6 NTCM. Medan 23-25 Juni 2011. th

  22. Peserta Workshop “Management Acute Coronary Syndrome”. The 6 NTCM. Medan 23-25 Juni 2011.

  23. Peserta Workshop “Management Acute and Chronic Heart Failure”. The th 6 NTCM. Medan 23-25 Juni 2011.

  

24. Peserta Simposium “The Future Management Cardiovascular

th

  Management ”. The 6 New Trend in Cardiovascular Management

(NTCM). Departemen Kardiologi dan Vaskular Medicine. Medan, 23 – 25

Juni 2011.

  25. Peserta Simposium “Achieving Ambitious Glycaemic Target in Diabetes : Stepwise Treatment From Sulfonilurea to Insulin Initiation &

Intensification (Basal and Basal Plus). Perkeni Sumut. Medan, 3 Juli 2011.

  

26. Peserta Workshop Penyuntikan Intraartikuler. Rheumatology Update

2011. Medan, 07 Juli 2011.

  

27. Panitia Rheumatologi Update Departemen Penyakit Dalam FK USU,

Medan 9-10 juli 2011.

  

28. Peserta Seminar Sehari Lymphoma Update : Deteksi Dini dan

Penatalaksanaan. Medan, 16 Juli 2011.

  

29. Peserta Seminar Update. Gedung Abdul Hakim, HUT FK USU ke 59,

Sabtu, 30 Juli 2011.

  30. Peserta Seminar Update. HUT FK USU Ke-59. Medan, 30 Juli 2011.

  31. Peserta Workshop “Course Cum Workshop on Hypertension for Clinical Practice”. Medan 10 September 2011.

  32. Peserta Roadshow “Medskup Cardio-Workshop Gastroentero-Hepatology

& Infection-Immunology”, Grand Aston City Hall Medan, 8 Oktober

2011.

  33. Peserta Workshop Ascites Gastroentero-hepatologi Update IX 2011, PPHI-PGI-PEGI- Divisi Gastroentero-Hepatologi Departemen Ilmu Penyakit Dalam FK USU, Medan, 03-05 November 2011.

  34. Peserta Workshop Hepatitis B dan C Gastroentero-hepatologi Update IX

2011 , PPHI-PGI-PEGI- Divisi Gastroentero-Hepatologi Departemen Ilmu

Penyakit Dalam FK USU, Medan, 03-05 November 2011

  

35. Peserta Workshop Ensefalopati Hepatik Gastroentero-hepatologi Update

, PPHI-PGI-PEGI- Divisi Gastroentero-Hepatologi Departemen

  IX 2011 Ilmu Penyakit Dalam FK USU, Medan, 03-05 November 2011.

  

36. Peserta Simposium Perdarahan Saluran Cerna, Gastroentero-Hepatologi

Update IX 2010, Convention Hall Hotel Danau Toba Medan, 4-5

November 2011.

  

37. Panitia Pelatihan Program Pengembangan Pendidikan Keprofesian

Berkelanjutan Ultrasonografi Tahap kedua bagi Spesialis dan PPDS Penyakit Dalam. Departemen Penyakit Dalam FK USU dan PUSKI. Medan, 8-10 November 2011.

  

38. Peserta Mini Symposium “Patophysiology and Recent Management of

”. Medan, 13 November 2011.

  Chronic Constipation and Acute Diarrhea

  

39. Peserta Simposium “ Pathogenesis, Prevention and Management Diabetic

Vascular Complications”. Medan, 20 Nopember 2011.

  

40. Peserta Round Table Discussion “Modifikasi Penggunaan Ekstrak Bahan

Alami untuk Pengobatan Tukak Lambung”. Hotel JW Marriot Medan, 3

Desember 2011.

  

41. Peserta Simposium dan Workshop Head CT Scan “Clinical and Radiology

Approach of Stroke and Head Injury”. Gedung Abdul Hakim FK USU

Medan, 17 Desember 2011.

  

42. Peserta Simposium dan “The Management of Stroke Prevention: Current

Updates”. IDI Wilayah Medan, 5 Februari 2012.

  

43. Peserta Simposium “Cancer Pain Management”. Hotel Grand Aston

Medan, 10 Maret 2012.

  

44. Panitia Simposium dan Workshop “Diabetes Update for Excellent”. Hotel

JW Marriot Medan, 17 Maret 2012.

  

45. Peserta Simposium “Diabetes Update for Excellent”. Hotel JW Marriot

Medan, 17 Maret 2012.

  

46. Peserta Workshop “Diabetes Update for Excellent”. Hotel JW Marriot

Medan, 17 Maret 2012.

  

47. Peserta Pelatihan Program Pengembangan Pendidikan Keprofesian

Berkelanjutan FK USU Seminar “Management of Diagnostic Approach of

Malaria” . Gedung Abdul Hakim FK USU, 3 Maret 2012.

  

48. Peserta Seminar dan Workshop on Managing Metabolic Syndrome “ Good

Doctor for The Perfect Metabolism”. Santika Dyandra Hotel, 14 April

2012.

  

49. Pembicara Makalah Hasil Penelitian pada Kongres Nasional PERPARI

  XII di Makassar 25-27 Mei 2012. ( Juara 2 Presentasi Oral)

  

50. Peserta Workshop Infection Update V Diagnostik dan Manajemen Terkini

di Bidang Penyakit Dalam, Fokus Pada Infeksi. Medan, 6-8 Juni 2012.

  

51. Peserta Simposium Infection Update V Diagnostik dan Manajemen

Terkini di Bidang Penyakit Dalam, Fokus Pada Infeksi . Medan, 6-8 Juni

2012.

  

52. Peserta dan Presenter Poster Kongres Nasional XV Perhimpunan Dokter

Spesialis Penyakit Dalam Indonesia (KOPAPDI XV) Medan, 12 - 15

Desember 2012.

  

53. Peserta Workshop Terapi Insulin Kongres Nasional XV Perhimpunan

Dokter Spesialis Penyakit Dalam Indonesia (KOPAPDI XV) Medan, 12 -

15 Desember 2012.

  th

  

54. Peserta Simposium The 5 Endocrinology & Diabetes of Sumatera Region

(FEDS-5) Theme : “The Endocrine-Metabolic Disease : Present and Future”. Hotel JW Marriot Medan, 22-23 Februari 2013.